Subscribe to Newsletter

Technology and Equipment

Discovery & Development Business Practice

Assessing Drug Encapsulation Efficiency using Nanoparticle Tracking Analysis

In this application note we describe the use of Nanoparticle Tracking Analysis (NTA) for size and concentration measurements of drug delivery nanoparticles. In addition, by using a fluorescently tagged drug molecule, it was possible to determine how many drug delivery nanoparticles had successfully been loaded with drug molecules.

Discovery & Development Business Practice

NanoSight Nanoparticle Tracking Analysis Concentration Measurement

The ability to compare concentration data across users, instruments and sites is a key requirement for many applications. Concentration repeatability and reproducibility are greatly improved with the application of the NTA concentration measurement upgrade, which has also been shown to reduce the influence of user selected capture and analysis settings on measurements. This application note describes the improvement in accuracy and precision of concentration measurements over a wide range of sample sizes, concentrations and materials.

Discovery & Development Business Practice

Relative viscosity screening of monoclonal antibody formulations at low concentration and viscosity

Viscosizer TD provides automated relative viscosity measurements with high reproducibility at low viscosity, to help identify molecules with abnormally high viscosity-concentration profiles at low sample concentrations as early as possible in the development pipeline

Manufacture Technology and Equipment

Better Together

| Vijay Chudasama

Antibody drug conjugates offer a great deal of potential for drug targeting, but what’s the best way of linking drugs and antibodies?

Manufacture Technology and Equipment

Welcome to (Virtual) Reality

| Stephanie Vine

VR is creating a buzz, but is it a game changer or gimmick?

Manufacture Packaging

Glass delamination brought under control

Dr. Bernhard Hladik from SCHOTT breaks down the delamination phenomenon and describes how pharma manufacturers can effectively fight back.

Manufacture Small Molecules

Moving from Batch to Continuous

| James Strachan

The first switch from batch to continuous manufacturing has been made – and approved by the FDA. Will pharma’s future be continuous?

Manufacture Drug Delivery

Harnessing Adeno-Associated Viruses

| James Strachan

AAV vectors are a promising tool for gene therapy and regenerative medicine, but only if they can be manufactured efficiently

Discovery & Development Technology and Equipment

Bio-Responsive Insulin Delivery

| James Strachan

A “smart” synthetic patch uses live pancreatic cells to painlessly deliver insulin through microneedles – on demand

Discovery & Development Business Practice

Morphologically-Directed Raman Spectroscopy used for the characterization of protein aggregates in suspension

This application note explores the use of the Morphologi G3-ID for Morphologically-Directed Raman spectroscopy (MDRS) to identify and analyze contaminants including protein aggregates present in a stressed sample of lysozyme, and to compare particles held in suspension within a thin path wet cell with those collected on a filter membrane.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register